In rats with complete Freund's adjuvant‐induced arthritis, intrathecal injection of a Nogo‐A receptor antagonist has been shown to reduce the TRPV1 content in the DRG and effectively relieve chronic pain [24]. Here, TRPV1 is linked to Arthritis.